Amniotic Fluid Stem Cells Inhibit the Progression of Bleomycin-Induced Pulmonary Fibrosis via CCL2 Modulation in Bronchoalveolar Lavage

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Garcia, Orquidea ^a,b   Carraro, Gianni ^a   Turcatel, Gianluca ^a   Hall, Marisa ^a   Sedrakyan, Sargis ^a   Roche, Tyler ^a   Buckley, Sue ^a   Driscoll, Barbara ^a,b   Perin, Laura ^a   Warburton, David ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN; GELATINASE A; MONOCYTE CHEMOTACTIC PROTEIN 1;

AMNION FLUID; AMNIOTIC FLUID STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; FETUS; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LONG TERM CARE; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SHORT COURSE THERAPY; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE;

AMNIOTIC FLUID; ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE; CHEMOKINE CCL2; CHEMOTAXIS; COCULTURE TECHNIQUES; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FETUS; HUMANS; INFLAMMATION MEDIATORS; LUNG; MALE; MATRIX METALLOPROTEINASE 2; MICE; MODELS, BIOLOGICAL; PNEUMOCYTES; PREGNANCY; PROTEOLYSIS; PULMONARY FIBROSIS; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS;

EID: 84881505980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071679     Document Type: Article

References (73)

1. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G, (2006) Incidence and Prevalence of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 174: 810-826.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824.
3. Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, et al. (2009) Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 181: 254-263.
4. Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, et al. (2009) Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol 69: 268-274.
5. Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, et al. (1998) Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 46: 223-231.
6. Agostini C, Gurrieri C, (2006) Chemokine/Cytokine Cocktail in Idiopathic Pulmonary Fibrosis. Proceedings of the American Thoracic Society 3: 357-363.
7. Mercer PF, Johns RH, Scotton CJ, Krupiczojc MA, Konigshoff M, et al. (2009) Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am J Respir Crit Care Med 179: 414-425.
8. Baran CP, Opalek JM, McMaken S, Newland CA, O'Brien JM Jr, et al. (2007) Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 176: 78-89.
9. Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, et al. (2009) Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78: 285-292.
10. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, et al. (1994) Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149: 655-659.
11. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, et al. (1999) Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14: 376-382.
12. Ekert JE, Murray LA, Das AM, Sheng H, Giles-Komar J, et al. (2011) Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine lung fibrocytes. BioMed Central Fibrogenesis and Tissue Repair 4.
13. Liu X, Das AM, Siedeman J, Griswold D, Afuh CN, et al. (2007) The CC Chemokine Ligand 2 (CCL2) Mediates Fibroblast Survival through IL-6. American Journal of Respiratory Cell and Molecular Biology 37: 121-128.
14. Gharaee-Kermani M, Denholm EM, Phan SH, (1996) Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271: 17779-17784.
15. Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, et al. (2011) New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. American Journal of Physiology-Lung Cellular and Molecular Physiology 300: 341-353.
16. Moore BB, III RP, Christensen PJ, Moore TA, Sitterding S, et al. (2001) Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling. The Journal of Immunology 167: 4368-4377.
17. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, et al. (2005) CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury. The American Journal of Pathology 166: 675-684.
18. Gharaee-Kermani M, McCullumsnith RE, Charo IF, Kunkel SL, Phan SH, (2003) CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. Cytokine 24: 266-276.
19. Inoshima I, Kuwano K, Hamada N, Hagimoto N, Yoshimi M, et al. (2004) Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 286: 1038-1044.
20. Weiss DJ, Bertoncello I, Borok Z, Kim C, Panoskaltsis-Mortari A, et al. (2011) Vermont Stem Cell Conference: Stem Cells and Cell Therapies in Lung Biology and Lung Diseases. Proceedings of the American Thoracic Society 8: 223-272.
21. Warburton D, Perin L, DeFilippo R, Bellusci S, Shi W, et al. (2008) Stem/Progenitor Cells in Lung Development, Injury Repair, and Regeneration. Proceedings of the American Thoracic Society 5: 703-706.
22. Neuringer IP, Randell SH (2004) Stem cells and repair of lung injuries. bioMed Central Respiratory Research 5.
23. Toonkel RL, Hare JM, Matthay MA, Glassberg MK (2013) Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis: Potential for Clinical Testing. American Journal of Respiratory and Critical Care Medicine.
24. Rojas M, Xu J, Woods CR, Mora AL, Spears W, et al. (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152.
25. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, et al. (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175: 303-313.
26. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, et al. (2004) Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 172: 1266-1272.
27. Vosdoganes P, Wallace EM, Chan ST, Acharya R, Moss TJ, et al. (2012) Human amnion epithelial cells repair established lung injury. Cell Transplant.
28. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, et al. (2010) Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 182: 643-651.
29. Serrano-Mollar A, Nacher M, Gay-Jordi G, Closa D, Xaubet A, et al. (2007) Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 176: 1261-1268.
30. Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, et al. (2009) Transplantation of Allogenic and Xenogenic Placenta Derived Cells Reduces Bleomycin-Induced Lung Fibrosis. Cell Transplantation 18: 405-422.
31. Abe S, Boyer C, Liu X, Wen FQ, Kobayashi T, et al. (2004) Cells derived from the circulation contribute to the repair of lung injury. Am J Respir Crit Care Med 170: 1158-1163.
32. Aguilar S, Scotton CJ, McNulty K, Nye E, Stamp G, et al. (2009) Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 4: e8013.
33. Murphy S, Lim R, Dickinson H, Acharya R, Rosli S, et al. (2011) Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant 20: 909-923.
34. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, et al. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100: 8407-8411.
35. Walker N, Badri L, Wettlaufer S, Flint A, Sajjan U, et al. (2011) Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. American Journal of Pathology 178: 2461-2469.
36. Antoniou K, Papadaki H, Soufla G, Kastrinaki M, Damianaki A, et al. (2010) Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Respiratory Medicine 104: 1535-1542.
37. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
38. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, et al. (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104: 11002-11007.
39. Cargnoni A, Ressel L, Rossi D, Poli A, Arienti D, et al. (2012) Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy 14: 153-161.
40. Maguire CT, Demarest BL, Hill JT, Palmer JD, Brothman AR, et al. (2013) Genome-wide analysis reveals the unique stem cell identity of human amniocytes. PLoS One 8: e53372.
41. Coppi PD, Jr GB, Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology 25: 100-106.
42. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, et al. (2008) Human Amniotic Fluid Stem Cells Can Integrate and Differentiate into Epithelial Lung Lineages. Stem Cells 26: 2902-2911.
43. Moschidou D, Mukherjee S, Blundell M, Drews K, Jones G, et al. (2012) Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Molecular Therapy 20: 1953-1967.
44. Perin L, Sedrakyan S, Giuliani S, Sacco SD, Carraro G, et al. (2010) Protective Effect of Human Amniotic Fluid Stem Cells in an Immunodeficient Mouse Model of Acute Tubular Necrosis. PLoS ONE 5: e9357.
45. Sedrakyan S, Sacco SD, Milanesi A, Shiri L, Petrosyan A, et al. (2012) Injection of amniotic fluid stem cells delays progression of renal fibrosis. Journal of the American Society of Nephrology 23: 661-673.
46. Moore BB, Hogaboam CM, (2007) Murine models of pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 294: 152-160.
47. Manali ED, Moschos C, Triantafillidou C, Kotanidou A, Psallidas I, et al. (2011) Static and dynamic mechanics of the murine lung after intratracheal bleomycin. BioMed Central Pulmonary Medicine 11.
48. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH, (1994) Lung Monocyte Chemoattractant Protein-1 Gene Expression in Bleomycin-Induced Pulmonary Fibrosis. The Journal of Immunology 153: 4733-4741.
49. Smith RE, Strieter RM, Phan SH, Kunkel SL, (1996) C-C Chemokines: Novel Mediators of the Profibrotic Inflammatory Response to Bleomycin Challenge. American Journal of Respiratory Cell and Molecular Biology 15: 693-702.
50. Denney H, Clench MR, Woodroofe MN, (2009) Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and-9: Implications for chemotaxis. Biochemical and Biophysical Research Communications 382: 341-347.
51. Dean R, Cox J, Bellac C, Doucet A, Starr A, et al. (2008) Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2,-7,-8m and-13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112: 3455-3464.
52. McQuibban GA, Gong J-H, Wong JP, Wallace JL, Clark-Lewis I, et al. (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100: 1160-1167.
53. Buckley S, Shi W, Carraro G, Sedrakyan S, Sacco SD, et al. (2011) The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors. American Journal of Respiratory Cell and Molecular Biology 45: 1212-1221.
54. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, et al. (2007) Renal differentiation of amniotic fluid stem cells. Cell Proliferation 40: 936-948.
55. Ashcroft T, Simpson JM, Timbrell V, (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. Journal of Clinical Pathology 41: 467-470.
56. Harris RS, (2005) Pressure-Volume Curves of the Respiratory System. Respiratory Care 50: 78-98.
57. Lee J, Reddy R, Barsky L, Weinberg K, Driscoll B, (2005) Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. American Journal of Physiology-Lung Cellular and Molecular Physiology 290: 684-693.
58. Wesselius LJ, Catanzaro A, Wasserman SI, (1984) Neutrophil chemotactic activity generation by alveolar macrophages after bleomycin injury. Am Rev Respir Dis 129: 485-490.
59. Sato E, Koyama S, Masubuchi T, Takamizawa A, Kubo K, et al. (1999) Bleomycin stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activities. Am J Physiol 276: L941-950.
60. Takamizawa A, Koyama S, Sato E, Masubuchi T, Kubo K, et al. (1999) Bleomycin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity. J Immunol 162: 6200-6208.
61. Deshmane S, Kremlev S, Amini S, Sawaya B, (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon Cytokine Research 29: 313-326.
62. Car B, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, et al. (1994) Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine 149: 655-659.
63. Garcia-de-Alba C, Becerril C, Ruiz V, Gonzalez Y, Reyes S, et al. (2010) Expression of Matrix Metalloproteases by Fibrocytes: Possible Role in Migration and Homing. American Journal of Respiratory and Critical Care Medicine 182: 1144-1152.
64. Carulli MT, Ong VH, Ponticos M, Shiwen X, Abraham DJ,et al. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: Evidence for autocrine regulation of myofibroblast differentiation.
65. King TE, Pardo A, Selman M, (2011) Idiopathic pulmonary fibrosis. The Lancet 378: 1949-1961.
66. Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, et al. (2009) Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78: 285-292.
67. Antoniades H, Neville-Golden J, Galanopoulos T, Kradin R, Valente A, et al. (1992) Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proceedings of the National Academy of Sciences 89: 5371-5375.
68. Prasse A, Muller-Quernheim J, (2009) Non-invasive biomarkers in pulmonary fibrosis. Respirology 14: 788-795.
69. Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, et al. (2008) Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112: 256-263.
70. Dancer R, Wood A, Thickett D, (2011) Metalloproteinases in idiopathic pulmonary fibrosis. European Respiratory Journal 38: 1461-1467.
71. Rull A, Camps J, Alonso-Villaverde C, Joven J (2010) Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism. Mediators of Inflammation 2010.
72. Miyamoto K, Ninomiya K, Sonoda KH, Miyauchi Y, Hoshi H, et al. (2009) MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. Biochem Biophys Res Commun 383: 373-377.
73. McNulty K, James SM, (2012) Stem Cells and Pulmonary Fibrosis: Cause or Cure? Proceedings of the American Thoracic Society 9: 164-171.